Structure Therapeutics Inc. American Depositary Shares GPCR
Analyst Ratings
- Consensus
- Buy — 10 Buy · 0 Hold · 0 Sell (10 analysts)
- Avg. Price Target
- $106.20 (+163.0% upside)
Key Stats
- Today's Range
- $40.26 – $47.38
- 50-Day Range
- $40.26 – $57.07
- 52-Week Range
- $15.80 – $94.90
- Volume
- 3.41 million shs
- Average Volume
- 738K shs
- Market Cap
- $2.88 billion
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 2.13
- Price / Sales
- —
Short Interest
- Short Interest
- 0.02%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- —
- Net Income
- $-214,835,000
- Net Margin
- —
- Return on Equity
- -15.86%
- Debt-to-Equity
- —
About Structure Therapeutics Inc. American Depositary Shares
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
Related Stocks
Compare head-to-head: GPCR vs LLY·GPCR vs JNJ·GPCR vs ABBV·GPCR vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.